Phase 3 Readout~month

Phase 3 Topline: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Nalbuphi

Indication
Idiopathic Pulmonary Fibrosis

Other upcoming events for TRVI

Phase 2 ReadoutPhase 2 Readout: haduvio
Phase 2 ReadoutPhase 2 Readout: haduvio

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Nalbuphi — TRVI Phase 3 Readout | BioSniper